Enlarged Prostate (BPH) Treatments
Find Enlarged Prostate (BPH) Treatments
Medications for Enlarged Prostate (BPH)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Enlarged Prostate (BPH).
Found 7 Approved Drugs for Enlarged Prostate (BPH)
Tamsulosin
Generic Name
Tamsulosin
Tamsulosin
Generic Name
Tamsulosin
Form: Capsule
Method of administration: Oral
FDA approval date: April 27, 2010
Classification: alpha-Adrenergic Blocker
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules are an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension.
Jalyn
Generic Name
Dutasteride
Jalyn
Generic Name
Dutasteride
Form: Capsule
Method of administration: Oral
FDA approval date: November 02, 2015
Classification: 5-alpha Reductase Inhibitor
JALYN is a combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
Cardura
Generic Name
Doxazosin
Cardura
Generic Name
Doxazosin
Form: Tablet
Method of administration: Oral
FDA approval date: October 18, 2000
Classification: alpha-Adrenergic Blocker
CARDURA ® XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). CARDURA XL is not indicated for the treatment of hypertension. CARDURA XL is an alpha 1 adrenergic antagonist indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. ( 1 ) CARDURA XL is not indicated for the treatment of hypertension. ( 1 )
Tezruly
Generic Name
Terazosin
Tezruly
Generic Name
Terazosin
Form: Capsule, Solution
Method of administration: Oral
FDA approval date: December 20, 2004
Classification: alpha-Adrenergic Blocker
TEZRULY TM (terazosin) is an alpha-1 adrenoceptor antagonist indicated for: The treatment of signs and symptoms of benign prostatic hyperplasia (BPH).
Tadalafil
Brand Names
Adcirca, ALYQ, Cialis, Opsynvi, Tadliq
Tadalafil
Brand Names
Adcirca, ALYQ, Cialis, Opsynvi, Tadliq
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: November 26, 2003
Classification: Phosphodiesterase 5 Inhibitor
ADCIRCA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%).
Showing 1-5 of 7
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances